NewLink Genetics Competitors and Similar CompaniesClear all
NewLink Genetics's competitors and similar companies include CytomX Therapeutics and Sirnaomics US.
 NewLink Genetics NewLink Genetics, a biopharmaceutical company, develops therapeutic and diagnostic agents for patients with cancer and infectious diseases. |  CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. |  Sirnaomics US Sirnaomics is a biopharmaceutical company developing oncology therapeutics by using RNA interference (RNAi) technology. | |
Founding Date | Founding Date 1999 | Founding Date 2008 | Founding Date 2007 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Ames, US HQ Austin, US Devens, US | Locations South San Francisco, US HQ | Locations Germantown, US HQ Cambridge, US |
Employees | Employees 2162% decrease | Employees 15815% increase | Employees 3211% decrease |
Valuation ($) | Valuation ($) 33.2 m | Valuation ($) 78 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $230k (FY, 2021) | Revenue (est.) $76.2m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($30.4m) (FY, 2021) | Net income ($17.4m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 45.2m | Total funding raised $ 132.4m | Total funding raised $ 162m |
For sources of this data, please see the company profile
View Company Profiles
CytomX Therapeutics
HQ
South San Francisco, US
Employees
158↑ 15% increase
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
View companySirnaomics US
HQ
Germantown, US
Sirnaomics is a biopharmaceutical company developing oncology therapeutics by using RNA interference (RNAi) technology.
View company